Baird lowered the firm’s price target on Intuitive Surgical to $436 from $440 and keeps an Outperform rating on the shares. The firm said their ereport beat on every level and while Baird still expects P&L variability as the new system rolls out, they are now beginning to see early, encouraging signs there is a greater propensity for out-year revenue/EPS upside.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ISRG:
- Intuitive Surgical Stock (NASDAQ:ISRG) Gains after Q1 Earnings Beat
- Options Volatility and Implied Earnings Moves Today, April 18, 2024
- ISRG Upcoming Earnings Report: What to Expect?
- Intuitive Surgical added to ‘US 1 List’ at BofA, Lowe’s removed
- Intuitive Surgical price target raised to $430 from $420 at Stifel
